• Five-year sales agreement with US-based Select Medical to offer dorsaVi products across 1,900+ outpatient physical therapy centres
• 18-month development pilot to ensure technology met therapists' needs, including collecting accurate clinical data for athlete rehabilitation and return to play assessments
• dorsaVi products available for purchase starting September 2025

dorsaVi (ASX:DVL) has signed a new five-year sales agreement with US-based Select Medical to offer purchasing options for its products across Select Medical's national network of 1,900+ outpatient physical therapy centres. The two entities underwent an 18-month development pilot to ensure the technology met therapists' needs, including the collection of accurate and useful clinical data to assist in the rehabilitation of injured athletes and return to play assessments. There is no contractual obligation to procure products, including no quantity guarantees. Andrew Ronchi, CEO of dorsaVi, said the company is delighted to have the opportunity to work with Select Medical, one of the largest providers of outpatient rehabilitation clinics in the United States, and that dorsaVi's technology will have an opportunity to play a pivotal role in patient assessment and rehabilitation.